详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Wang, Shanshan[1,2,3,4,5,6,7,8,9,10,11,12,13,14] *

; Fu, Cheng[1,2,3,4,5,6,7,8,9,10,11,12,13,14]

; Zou, Qing[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Li, Youyuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; He, Dalin[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Wang, Shaogang[1,2,3,4,5,6,7,8,9,10,11,12,13,14]

; Wang, Hongkai[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Smith, Matthew Raymond[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Tombal, Bertrand F.[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Hussain, Maha H. A.[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Niu, Yi[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Cai, Ling[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Hu, Nan[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Huang, Shiyun[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Kapur, Shivani[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Li, Rui[1,2,3,4,5,6,7,8,9,10,11,12,13,14]

; Kuss, Iris[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ; Ye, Dingwei[1,2,3,4,5,6,7,8,9,10,11,12,13,14] ;

单位： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [2]Liaoning Tumour Hosp, Shenyang, Peoples R China [3]Jiangsu Canc Hosp, Nanjing, Peoples R China [4]Hubei Canc Hosp, Wuhan, Peoples R China [5]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [7]Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA [8]Harvard Med Sch, Boston, MA USA [9]UCLouvain, Clin Univ St Luc, Div Urol, IREC, Brussels, Belgium [10]Northwestern Univ, Feinberg Sch Med, Chicago, IL USA [11]Bayer Healthcare Co Ltd, Beijing, Peoples R China [12]Bayer SEA, Singapore, Singapore [13]Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA [14]Bayer AG, Berlin, Germany

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [2]Liaoning Tumour Hosp, Shenyang, Peoples R China [3]Jiangsu Canc Hosp, Nanjing, Peoples R China [4]Hubei Canc Hosp, Wuhan, Peoples R China [5]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [7]Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA [8]Harvard Med Sch, Boston, MA USA [9]UCLouvain, Clin Univ St Luc, Div Urol, IREC, Brussels, Belgium [10]Northwestern Univ, Feinberg Sch Med, Chicago, IL USA [11]Bayer Healthcare Co Ltd, Beijing, Peoples R China [12]Bayer SEA, Singapore, Singapore [13]Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA [14]Bayer AG, Berlin, Germany

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and safety of darolutamide in Chinese patients with metastatic hormone-sensitive prostate cancer (mHSPC): A subpopulation analysis of the phase 3 ARASENS study

文献详情